Title: Epigenetic Therapy
1Epigenetic Therapy
- Jean-Pierre Issa
- University of Texas at MD Anderson Cancer Center
2Epigenetics
- Clonal and irreversible changes in gene
expression that cannot be attributed to changes
in DNA sequence - Silencing refers to epigenetic loss of expression
that is equivalent to an inactivating mutation
3Epigenetic Mechanisms
- Post-transcriptional
- RNAi
- Transcriptional
- Histone modifications
- DNA methylation
4DNA Methylation Patterns in the Genome
Most Autosomal Genes
Inactive X-Chromosome / Imprinted genes
5ER Methylation and Age in Normal Colon
25
20
15
ER Methylation
10
5
0
0
10
20
30
40
50
60
70
80
90
100
Age
6ER Methylation in Normal Distal Colon
7P14ARF Methylation in Normal Colon
8Methylation in Normal Tissues
Most stem cells unmethylated A few highly
methylated (and silenced)
Most stem cells lightly methylated No or minimal
silencing
9Epigenetic Mosaicism in Aging Tissues
10Epigenetic Mosaicism in Aging Tissues
11A Model of CpG island Methylation In Aging And
Cancer
No local susceptibility
Methylation Center
Local susceptibility strong protection
Local susceptibility loss of protection
12Noise in Gene Expression
Gene A
Gene B
Elowitz et al., Science 297(5584)1183-1186, 2002
13An Epigenetic View of Life (and Death)
14An Epigenetic View of Life (and Death)
15DNMT-I
HDAC-I
16Epigenetic Therapy Restoration of Gene Function
17Hypomethylating Cytosine Analogues
18(No Transcript)
19DAC Phase I Biologic
20HDAC Inhibitors Clinical Trials
- Butyrate, Phenylbutyrate
- Depsipeptide
- SAHA
- MS-275
- Valproic acid
21Summary
- Aging in humans is accompanied by deregulation of
epigenetic mechanisms, leading to epigenetic
mosaicism in stem cells - We hypothesize that epigenetic mosaicism shortens
lifespan by promoting the emergence of focal
proliferative disorders - Epigenetic therapy partially restores the
expression and function of silenced genes - Epigenetic therapy has shown promising results in
the treatment of cancer
22Acknowledgements
- Allen Yang
- Lanlan Shen
- Guillermo-Garcia Manero
- Hagop Kantarjian
- The Leukemia Department at MDACC
- Funding NCI, SUPERGEN, DoD, George Barbara
Bush Endowment - Disclaimer Consultant for epigenomics